Catalyst Wire Dossier Catalyst Wire Dossier

NORELGESTROMIN AND ETHINLY ESTRADIOL

NORELGESTROMIN AND ETHINYL ESTRADIOL · Amneal Pharmaceuticals NY LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NORELGESTROMIN AND ETHINLY ESTRADIOL, covering 2021-02-25 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: NORELGESTROMIN AND ETHINLY ESTRADIOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)

See pricing